Journal of the Korean Ophthalmological Society 2005;46(12):2028-2036.
Published online December 31, 2005.
Efficacy of Screening with Topical Steroids before Intravitreal Triamcinolone Injection.
Young Jung Roh, Wung Jae Kim, Jung Il Moon
Department of Ophthalmology, St. Mary's Hospital The Catholic University of Korea, College of Medicine, Seoul, Korea. jimoon@cathlic.ac.kr
유리체내 트리암시놀론 주입 전 스테로이드 점안 선별검사의 유용성
노영정,김웅재,문정일
Department of Ophthalmology, St. Mary`s Hospital The Catholic University of Korea, College of Medicine, Seoul, Korea
Correspondence:  Young-Jung Roh, M.D.
Abstract
PURPOSE
To evaluate the efficacy of screening of high risk groups with topical steroids due to increased ocular pressure by intravitreal triamocinolone injection (IVTA). METHODS: We selected 96 eyes that had undergone IVTA between January 2003 and December 2004. The screening method used was as follows; We administered 4 drops daily of prednisolone (1%) eye drops for 3weeks and included patients with an intraocular pressure increase of less than 5 mmHg for the procedure. Two groups consisting of the post-screening IVTA group (group A) and non-screening group (group B) were classified, and intraocular pressure was measured using a Goldman applanation tonometer at 1 week, 1 month, 2 months, 3 months and 6 months after the procedure. RESULTS: One patient in group A (3.1%) required glaucoma medication compared with 10 patients in group B (17.9%), and one of these group B patients required surgical intervention. Chi-square analysis showed a statistically significant reduction in glaucoma medication use in group A compared with group B (P<0.05). Group B had a higher percentage of patients with an increase of intraocular pressure over 5 mmHg compared with values before the procedure, particularly in the second and third months after the procedure. CONCLUSIONS: IVTA after screening resulted in less use of glaucoma medication and a reduced rate of increase in intraocular pressure. Complications due to increased intraocular pressure by IVTA can be minimized by screening high risk groups.
Key Words: Intraocular pressure;Screening;Triamcinolone


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next